Virbac's Technical Services Manager, Matt Wells, highlights the evolving epidemiology of leptospirosis in New Zealand, the associated heightened public health risk, and the role of newly developed Lepto 4-Way in managing this.
September 2023
We respect your privacy
This website uses cookies necessary for the proper functioning of the site and to facilitate your navigation. You will find more information about cookies, how we use them and how you can control their use by clicking here. By continuing your visit to this site, you agree that we use cookies, as specified in our policy.
You are about to leave the Virbac New Zealand website.
Regulatory constraints and medical practices vary from country to country. Consequently, the information provided on the site in which you are about to enter may not be suitable for use in your country.